Last updated 2026-07-20
- Acquired by Almeda Ventures, Mar 2021
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Anatomy Medical Technology Fund is a venture capital fund managed by Clal Biotechnology Industries (CBI). It leverages financial resources and business expertise to invest in promising Israeli medical device companies. The fund operated in two stages, with its investment period now concluded.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences2
Q&A
- What is Anatomy Medical Technology Fund's primary investment focus?
- Anatomy Medical Technology Fund primarily invests in the Health Tech & Life Sciences sector, with both of its recorded portfolio companies operating in this area.
- Can you name some of Anatomy Medical Technology Fund's portfolio companies?
- Anatomy Medical Technology Fund's portfolio includes Colospan, which develops technology for colorectal surgery, and Pi-Cardia, focused on non-implant-based valve treatments.
- What was Anatomy Medical Technology Fund's most recent known investment?
- Anatomy Medical Technology Fund participated in a C Round for Pi-Cardia in September 2017, which raised $37M.
- What was Anatomy Medical Technology Fund's earliest known investment?
- Anatomy Medical Technology Fund invested in Colospan's Seed round in January 2016, which raised $17M.
- What stages does Anatomy Medical Technology Fund typically invest in?
- Anatomy Medical Technology Fund has participated in Seed and C Round investments, as seen with Colospan and Pi-Cardia respectively.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2012-1 |
|---|
Acquisitions & public offerings
Acquired by Almeda Ventures 2021-03